Patients with a polygenic chromosome 16q24.3 microdeletion including ANKRD11 and epilepsy had a poorer cognitive outcome in comparison with patients with truncating variants and epilepsy, but findings were not significant, possibly due to low numbers. Here, ANKRD11 is linked to epilepsy.